Literature DB >> 4067298

Antibody status to influenza A/Singapore/1/57(H2N2) in Finland during a period of outbreaks caused by H3N2 and H1N1 subtype viruses.

R Pyhälä.   

Abstract

The incidence of haemagglutination inhibition (HI) antibody (titre greater than or equal to 12) to influenza A/Singapore/1/57(H2N2) in sera collected from a Finnish population in the summer of 1981 was 58%. Subjects born after 1968 were essentially seronegative, and a comparable low HI antibody status was also recorded among the elderly, the lowest being in people born during the period 1901-10. A small increase in antibody titre to the H2N2 virus was observed in the different age groups after infections with the H3N2, but not the H1N1, subtype influenza A viruses. The heterotypic response, which could be due to HI or NA antibodies, was restricted almost exclusively to subjects already exhibiting this antibody in acute phase sera. Moreover, the anamnestic boosting was not as strong as that described in earlier studies from samples collected at the beginning of the present era of H3N2 viruses. At population level, the HI antibody status to H2N2 was about the same at the beginning and end of the follow-up period which covered eight epidemic seasons. The results are discussed with respect to the doctrine of 'original antigenic sin' and to the threat of re-emergence of the H2N2 viruses.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4067298      PMCID: PMC2129551          DOI: 10.1017/s0022172400062860

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  19 in total

1.  Serum HI antibody and protection against influenza: a follow-up survey at community level of three epidemics caused by different H3N2-variants.

Authors:  R Pyhälä; K Aho
Journal:  Int J Epidemiol       Date:  1975-06       Impact factor: 7.196

2.  Antigenic memory to influenza A viruses in man determined by monovalent vaccines.

Authors:  W M Marine; J E Thomas
Journal:  Postgrad Med J       Date:  1979-02       Impact factor: 2.401

Review 3.  On the origin of pandemic influenza viruses.

Authors:  R G Webster
Journal:  Curr Top Microbiol Immunol       Date:  1972       Impact factor: 4.291

4.  Antigenic memory in man in response to sequential infections with influenza A viruses.

Authors:  M Morita; T Suto; N Ishida
Journal:  J Infect Dis       Date:  1972-07       Impact factor: 5.226

5.  Recycling of Asian and Hong Kong influenza A virus hemagglutinins in man.

Authors:  N Masurel; W M Marine
Journal:  Am J Epidemiol       Date:  1973-01       Impact factor: 4.897

6.  Haemagglutinin relationships of Hong Kong(H3) and Asian(H2) influenza strains delineated by antigen-specific recombinants.

Authors:  W R Dowdle; W M Marine; M Coleman; V Knez
Journal:  J Gen Virol       Date:  1972-08       Impact factor: 3.891

7.  Original antigenic sin to influenza in rats.

Authors:  L A Angelova
Journal:  Immunology       Date:  1982-05       Impact factor: 7.397

8.  Seroepidemiology of H1N1 influenza: the infection and re-infection rate in winter 1978-79.

Authors:  R Pyhälä; K Aho
Journal:  J Hyg (Lond)       Date:  1981-02

9.  Influenza A/Brazil/78(H1N1) infection in the elderly.

Authors:  U Mathur; D W Bentley; C B Hall; F K Roth; R G Douglas
Journal:  Am Rev Respir Dis       Date:  1981-06

10.  Immunological interrelationships of Hong Kong, Asian and equi-2 influenza viruses in man.

Authors:  W M Marine; W M Workman; R G Webster
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

View more
  9 in total

1.  H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers.

Authors:  Irina Isakova-Sivak; Marina Stukova; Mariana Erofeeva; Anatoly Naykhin; Svetlana Donina; Galina Petukhova; Victoria Kuznetsova; Irina Kiseleva; Tatiana Smolonogina; Irina Dubrovina; Maria Pisareva; Alexandra Nikiforova; Maureen Power; Jorge Flores; Larisa Rudenko
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Evaluation of multivalent H2 influenza pandemic vaccines in mice.

Authors:  Brian J Lenny; Stephanie Sonnberg; Angela F Danner; Kimberly Friedman; Richard J Webby; Robert G Webster; Jeremy C Jones
Journal:  Vaccine       Date:  2017-02-08       Impact factor: 3.641

3.  Human monoclonal antibodies to pandemic 1957 H2N2 and pandemic 1968 H3N2 influenza viruses.

Authors:  Jens C Krause; Tshidi Tsibane; Terrence M Tumpey; Chelsey J Huffman; Randy Albrecht; David L Blum; Irene Ramos; Ana Fernandez-Sesma; Kathryn M Edwards; Adolfo García-Sastre; Christopher F Basler; James E Crowe
Journal:  J Virol       Date:  2012-03-28       Impact factor: 5.103

4.  Assessment of transmission, pathogenesis and adaptation of H2 subtype influenza viruses in ferrets.

Authors:  Claudia Pappas; Hua Yang; Paul J Carney; Melissa B Pearce; Jacqueline M Katz; James Stevens; Terrence M Tumpey
Journal:  Virology       Date:  2015-02-05       Impact factor: 3.616

5.  B Cell Responses during Secondary Dengue Virus Infection Are Dominated by Highly Cross-Reactive, Memory-Derived Plasmablasts.

Authors:  Lalita Priyamvada; Alice Cho; Nattawat Onlamoon; Nai-Ying Zheng; Min Huang; Yevgeniy Kovalenkov; Kulkanya Chokephaibulkit; Nasikarn Angkasekwinai; Kovit Pattanapanyasat; Rafi Ahmed; Patrick C Wilson; Jens Wrammert
Journal:  J Virol       Date:  2016-05-27       Impact factor: 5.103

6.  Global host immune response: pathogenesis and transcriptional profiling of type A influenza viruses expressing the hemagglutinin and neuraminidase genes from the 1918 pandemic virus.

Authors:  John C Kash; Christopher F Basler; Adolfo García-Sastre; Victoria Carter; Rosalind Billharz; David E Swayne; Ronald M Przygodzki; Jeffery K Taubenberger; Michael G Katze; Terrence M Tumpey
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

7.  Humans and ferrets with prior H1N1 influenza virus infections do not exhibit evidence of original antigenic sin after infection or vaccination with the 2009 pandemic H1N1 influenza virus.

Authors:  Christopher D O'Donnell; Amber Wright; Leatrice Vogel; Kobporn Boonnak; John J Treanor; Kanta Subbarao
Journal:  Clin Vaccine Immunol       Date:  2014-03-19

8.  Development of a realtime RT-PCR assay for the rapid detection of influenza A(H2) viruses.

Authors:  Andrey Komissarov; Artem Fadeev; Anna Kosheleva; Kseniya Sintsova; Mikhail Grudinin
Journal:  Mol Cell Probes       Date:  2017-06-23       Impact factor: 2.365

9.  Development and pre-clinical evaluation of two LAIV strains against potentially pandemic H2N2 influenza virus.

Authors:  Irina Isakova-Sivak; Jørgen de Jonge; Tatiana Smolonogina; Andrey Rekstin; Geert van Amerongen; Harry van Dijken; Justin Mouthaan; Paul Roholl; Victoria Kuznetsova; Elena Doroshenko; Vadim Tsvetnitsky; Larisa Rudenko
Journal:  PLoS One       Date:  2014-07-24       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.